MDLinx Neuro Brief

CBD vs brain cancer, plus new studies show impact of sex and hormones on dementia

Good and bad news about dementia abounds this week, as MDLinx covers the incredible worldwide reductions in the disease (good news) that disproportionately benefit certain people (bad news), as well as risk factors for the disease we can all control (good news) and some we can’t (there’s that bad news again). Beyond dementia, we highlight…

Game-changing strategies detect Alzheimer’s extremely early, common condition found to be leading cause of dementia deaths, and more

This week we’ve got lots of good news (and a little bad) about Alzheimer’s disease—from incredible advancements in assessing risk factors (up to 50 years before onset) to the potential for a faster, cheaper, more accessible diagnosis, and even new ways a leukemia drug might make a big difference for patients suffering from the all-too-common…

A ‘cocktail’ for Alzheimer’s, an asthma drug for a notorious neuro disorder, and your brain on migraines

Although the coronavirus has put the brakes on a number of clinical trials and life-changing drug launches, it still hasn’t stopped neuroscientists from gaining new understandings of the brain and its many disorders. For example, could a certain cocktail prevent Alzheimer disease? Could a common asthma drug help treat a notorious neurodegenerative disease? And could…

×